A Study to Evaluate ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peri Mets

NCT04950166 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Peritoneal Carcinomatosis

Interventions

DRUG: pegsitacianine

Sponsor

OncoNano Medicine, Inc.